Drug: KARDEGIC Injury: Interstitial lung disease Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125916151 | KARDEGIC | Interstitial lung disease | MERCK | 73.08 YR | M | 0 | 20160726 | FR |
126027801 | KARDEGIC | Interstitial lung disease | ASTRAZENECA | 877.00 MON | M | 0 | 20160728 | FR |
126417001 | KARDEGIC | Interstitial lung disease | ASTRAZENECA | 23970.00 DY | M | 0 | 20160810 | FR |
126460051 | KARDEGIC | Interstitial lung disease | ASTRAZENECA | 65.00 YR | M | 0 | 20160811 | FR |
127016091 | KARDEGIC | Interstitial lung disease | PFIZER | 86.00 YR | F | 0 | 20160831 | FR |
127034821 | KARDEGIC | Interstitial lung disease | VALIDUS | 86.00 YR | F | 0 | 20160831 | FR |
Total Records: 6 Number of Pages: 1